Peripheral Airway Dysfunction in Obesity and Obese Asthma.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
04 2023
Historique:
received: 15 07 2022
revised: 30 11 2022
accepted: 20 12 2022
medline: 11 4 2023
pubmed: 8 1 2023
entrez: 7 1 2023
Statut: ppublish

Résumé

The purpose of this study was to investigate physiological phenotypes of asthma in obesity. Do physiological responses during bronchoconstriction distinguish different groups of asthma in people with obesity, and also differentiate from responses simply related to obesity? Cross-sectional study of people with obesity (31 with asthma and 22 without lung disease). Participants underwent methacholine challenge testing with measurement of spirometry and respiratory system impedance by oscillometry. Participants had class III obesity (BMI, 46.7 ± 6.6 kg/m Peripheral airway reactivity detected by oscillometry is common in obese control subjects and obese people with asthma. There is a subgroup of obese asthma characterized by significant peripheral airway dysfunction by oscillometry out of proportion to spirometric airway dysfunction. This peripheral dysfunction represents clinically significant respiratory disease not readily assessed by spirometry.

Sections du résumé

BACKGROUND
The purpose of this study was to investigate physiological phenotypes of asthma in obesity.
RESEARCH QUESTION
Do physiological responses during bronchoconstriction distinguish different groups of asthma in people with obesity, and also differentiate from responses simply related to obesity?
STUDY DESIGN AND METHODS
Cross-sectional study of people with obesity (31 with asthma and 22 without lung disease). Participants underwent methacholine challenge testing with measurement of spirometry and respiratory system impedance by oscillometry.
RESULTS
Participants had class III obesity (BMI, 46.7 ± 6.6 kg/m
INTERPRETATION
Peripheral airway reactivity detected by oscillometry is common in obese control subjects and obese people with asthma. There is a subgroup of obese asthma characterized by significant peripheral airway dysfunction by oscillometry out of proportion to spirometric airway dysfunction. This peripheral dysfunction represents clinically significant respiratory disease not readily assessed by spirometry.

Identifiants

pubmed: 36610669
pii: S0012-3692(23)00005-3
doi: 10.1016/j.chest.2022.12.030
pmc: PMC10107055
pii:
doi:

Substances chimiques

Methacholine Chloride 0W5ETF9M2K

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

753-762

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL133920
Pays : United States

Informations de copyright

Copyright © 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Références

Eur Respir J. 2020 Feb 27;55(2):
pubmed: 31772002
Am Rev Tuberc. 1959 Apr;79(4):457-67
pubmed: 13650117
J Allergy Clin Immunol. 2011 Sep;128(3):508-15.e1-2
pubmed: 21782230
Pediatr Pulmonol. 2011 Dec;46(12):1209-14
pubmed: 21634033
Ann Am Thorac Soc. 2022 Jan;19(1):135-139
pubmed: 34343031
Eur Respir Rev. 2022 Feb 9;31(163):
pubmed: 35140105
Am J Respir Crit Care Med. 2012 Oct 1;186(7):598-605
pubmed: 22837379
J Appl Physiol (1985). 2021 Jan 1;130(1):36-47
pubmed: 33119471
Eur Respir J. 2005 Sep;26(3):511-22
pubmed: 16135736
ERJ Open Res. 2020 Jul 20;6(2):
pubmed: 32714957
Am J Respir Crit Care Med. 2000 Jan;161(1):309-29
pubmed: 10619836
Allergy. 2014 Dec;69(12):1681-8
pubmed: 25123492
Eur Respir J. 1999 Oct;14(4):902-7
pubmed: 10573240
Pediatr Pulmonol. 2019 Aug;54(8):1162-1172
pubmed: 31211519
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
J Appl Physiol (1985). 2019 Dec 1;127(6):1772-1781
pubmed: 31647721
Am J Respir Cell Mol Biol. 2016 Aug;55(2):176-87
pubmed: 27064658
Am J Respir Crit Care Med. 2014 Jun 15;189(12):1494-502
pubmed: 24821412
J Allergy Clin Immunol. 2018 Apr;141(4):1169-1179
pubmed: 29627041
Int J Obes (Lond). 2008 Mar;32(3):502-9
pubmed: 17955030
Am J Respir Crit Care Med. 1999 Jan;159(1):179-87
pubmed: 9872837
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):545-554.e4
pubmed: 28866107

Auteurs

Anne E Dixon (AE)

Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT. Electronic address: anne.dixon@uvmhealth.org.

Matthew E Poynter (ME)

Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT.

Olivia Johnson Garrow (OJ)

Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT.

David A Kaminsky (DA)

Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT.

W G Tharp (WG)

Department of Anesthesiology, Larner College of Medicine, University of Vermont, Burlington, VT.

Jason H T Bates (JHT)

Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH